Most Novel Cancer Drug Approvals Based on Limited Evidence ...Middle East

Medscape - News
For the majority of novel cancer drugs that gain US approval, the approval is based on a single, often uncontrolled clinical trial that measures surrogate endpoints, with modest clinical benefits to patients. Medscape Medical News

Hence then, the article about most novel cancer drug approvals based on limited evidence was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Most Novel Cancer Drug Approvals Based on Limited Evidence )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News